Seattle Genetics Highlights ADCETRIS(R) (Brentuximab Vedotin) Phase 2 ... MarketWatch The phase 2 clinical trial presented at ASH has been expanded to include a treatment arm to assess the activity and tolerability of ADCETRIS in combination with Rituxan (rituximab) as well as an arm to evaluate single-agent ADCETRIS in patients with ... |
